Physician profile
Alan Guy
NPI 1275859217
$1,535.78
in general payments reported to CMS, 2019-2025
27 companies · $41.64 in 2025
The $41.64 reported for 2025 was less than what a typical Sports Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $119).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $246 · 2020: $88.27 · 2021: $125 · 2022: $417 · 2023: $89.84 · 2024: $529 · 2025: $41.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $660.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $660.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertos Medical, INC. | $200.72 | 2022-2024 | Mild Device Kit |
| Medtronic, INC. | $189.58 | 2021-2024 | Intellis Adaptivestim |
| Spr Therapeutics, INC | $170.75 | 2022-2024 | Sprint Pns System |
| Biotronik Nro, INC. | $147.83 | 2024 | Prospera |
| Zimmer Biomet Holdings, INC. | $130.54 | 2022 | |
| Pacira Therapeutics, INC. | $103.35 | 2019-2021 | |
| Abbott Laboratories | $74.51 | 2021-2025 | Octrode, Proclaim |
| Si-Bone, INC. | $54.94 | 2019-2020 | |
| Fidia Pharma USA INC. | $54.17 | 2019-2024 | Hymovis |
| Nalu Medical, INC. | $40.56 | 2022 | |
| Depuy Synthes Sales INC. | $39.80 | 2021-2022 | |
| Orthogenrx INC. | $31.37 | 2019 | |
| Medtronic USA, INC. | $30.21 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $29.53 | 2019 | |
| Stryker Corporation | $27.91 | 2023 | Spinejack |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Assertio Therapeutics, INC. | $26.43 | 2019 | |
| Avanos Medical | $25.56 | 2022 | |
| Nevro Corp. | $21.72 | 2021 | |
| Protega Pharmaceutials INC | $20.89 | 2025 | Roxybond |
| Endo USA, INC. | $16.47 | 2024 | Xiaflex |
| Daiichi Sankyo INC. | $15.86 | 2019 | |
| Boston Scientific Corporation | $14.66 | 2020 | |
| Kaleo, INC. | $14.29 | 2019 | |
| Pfizer INC. | $14.16 | 2019 | |
| Allergan, INC. | $13.86 | 2019 | |
| Bioventus LLC | $13.81 | 2022 | |
| Biodelivery Sciences International, INC. | $12.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Guy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.